X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22442) 22442
Book Review (2923) 2923
Publication (811) 811
Book Chapter (192) 192
Conference Proceeding (106) 106
Magazine Article (61) 61
Dissertation (35) 35
Book / eBook (7) 7
Newspaper Article (5) 5
Web Resource (4) 4
Data Set (3) 3
Streaming Video (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17894) 17894
humans (13653) 13653
male (10266) 10266
female (8114) 8114
levodopa (8023) 8023
parkinson disease - drug therapy (7393) 7393
levodopa - therapeutic use (7062) 7062
parkinson's disease (7021) 7021
clinical neurology (6308) 6308
middle aged (6297) 6297
animals (5852) 5852
aged (5678) 5678
neurosciences (4986) 4986
levodopa - pharmacology (3958) 3958
antiparkinson agents - therapeutic use (3553) 3553
adult (3340) 3340
levodopa - adverse effects (3276) 3276
rats (3081) 3081
parkinson disease - physiopathology (2795) 2795
dopamine (2724) 2724
levodopa - administration & dosage (2649) 2649
l-dopa (2555) 2555
pharmacology & pharmacy (2227) 2227
parkinsons-disease (2173) 2173
antiparkinson agents - adverse effects (2013) 2013
abridged index medicus (1974) 1974
dopa (1939) 1939
dopamine - metabolism (1697) 1697
parkinson disease - complications (1586) 1586
neurology (1572) 1572
time factors (1509) 1509
basal ganglia (1478) 1478
dose-response relationship, drug (1468) 1468
drug therapy, combination (1447) 1447
parkinsons disease (1394) 1394
treatment outcome (1363) 1363
movement disorders (1344) 1344
antiparkinson agents - administration & dosage (1260) 1260
motor fluctuations (1240) 1240
dyskinesia (1226) 1226
levodopa - metabolism (1208) 1208
psychiatry (1181) 1181
mice (1133) 1133
aged, 80 and over (1097) 1097
parkinson disease - therapy (1057) 1057
double-blind (1035) 1035
analysis (992) 992
brain (974) 974
carbidopa - therapeutic use (941) 941
disease models, animal (941) 941
parkinson disease - diagnosis (924) 924
disease (922) 922
motor activity - drug effects (901) 901
parkinson disease - metabolism (889) 889
parkinson’s disease (888) 888
severity of illness index (885) 885
neurodegenerative diseases (872) 872
parkinson disease (869) 869
drug combinations (860) 860
rats, sprague-dawley (854) 854
double-blind method (850) 850
therapy (842) 842
dopamine agonists - therapeutic use (837) 837
antiparkinson agents - pharmacology (828) 828
corpus striatum - metabolism (800) 800
neurons (795) 795
deep brain stimulation (794) 794
subthalamic nucleus (784) 784
corpus striatum - drug effects (745) 745
levodopa-induced dyskinesia (744) 744
brain - metabolism (739) 739
levodopa-induced dyskinesias (731) 731
parkinson disease - psychology (707) 707
phenols (706) 706
dopamine agents - therapeutic use (690) 690
follow-up studies (684) 684
levodopa - pharmacokinetics (684) 684
biochemistry & molecular biology (662) 662
dyskinesia, drug-induced - etiology (642) 642
research (640) 640
dopamine agents - pharmacology (632) 632
adolescent (623) 623
drug therapy (604) 604
carbidopa - administration & dosage (599) 599
striatum (598) 598
brain - drug effects (594) 594
surgery (584) 584
pharmacokinetics (583) 583
parkinsonian disorders - drug therapy (581) 581
care and treatment (580) 580
dopamine - physiology (571) 571
diagnosis (566) 566
carbidopa (561) 561
drug administration schedule (558) 558
parkinsonism (556) 556
substantia-nigra (529) 529
medicine, general & internal (527) 527
parkinson disease - pathology (526) 526
rats, wistar (520) 520
analysis of variance (518) 518
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20117) 20117
German (504) 504
French (417) 417
Russian (401) 401
Spanish (365) 365
Japanese (357) 357
Italian (160) 160
Polish (98) 98
Chinese (75) 75
Portuguese (54) 54
Hungarian (34) 34
Dutch (29) 29
Czech (20) 20
Swedish (14) 14
Norwegian (13) 13
Danish (12) 12
Finnish (12) 12
Serbian (12) 12
Hebrew (10) 10
Slovak (10) 10
Korean (9) 9
Turkish (7) 7
Romanian (6) 6
Bulgarian (4) 4
Slovenian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Persian (2) 2
Bosnian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Movement Disorders, ISSN 0885-3185, 04/2016, Volume 31, Issue 4, pp. 530 - 537
Journal Article
AAPS Journal, ISSN 1550-7416, 04/2013, Volume 15, Issue 2, pp. 316 - 323
Motor complications of Parkinson's disease (PD) are a consequence of pulsatile dopaminergic stimulation from standard oral levodopa therapy. Levodopa-carbidopa... 
Duodopa | Levodopa-carbidopa intestinal gel | Parkinson's disease | Pharmacokinetics | LCIG | ENTACAPONE | CONTINUOUS DOPAMINERGIC STIMULATION | ORAL LEVODOPA | LEVODOPA/CARBIDOPA | RELEASE | TRANSPORT | THERAPY | FLUCTUATIONS | L-DOPA | PHARMACOLOGY & PHARMACY | ABSORPTION | Humans | Middle Aged | Intubation, Gastrointestinal - instrumentation | Levodopa - pharmacokinetics | Male | Tyrosine - blood | Parkinson Disease - drug therapy | Tyrosine - analogs & derivatives | Intestinal Absorption | Jejunum - metabolism | Levodopa - chemistry | Sweden | Levodopa - administration & dosage | Biotransformation | Carbidopa - adverse effects | Antiparkinson Agents - chemistry | Female | Tyrosine - pharmacokinetics | Carbidopa - blood | Carbidopa - administration & dosage | Gels | Infusion Pumps | Carbidopa - pharmacokinetics | Carbidopa - chemistry | Antiparkinson Agents - adverse effects | Levodopa - blood | Chemistry, Pharmaceutical | Antiparkinson Agents - pharmacokinetics | Antiparkinson Agents - blood | Levodopa - adverse effects | Parkinson Disease - diagnosis | Aged | Antiparkinson Agents - administration & dosage | Parkinson Disease - blood | Drug Combinations | Germany | Complications and side effects | Neurosciences | Carbidopa | Metabolites | Universities and colleges | Dopa | Oral medication | Index Medicus | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 03/2017, Volume 83, Issue 3, pp. 540 - 553
Journal Article
Journal Article
CLINICAL INTERVENTIONS IN AGING, ISSN 1176-9092, 2010, Volume 5, pp. 229 - 238
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD).... 
Parkinson's disease | levodopa | motor fluctuations | dyskinesia | GERIATRICS & GERONTOLOGY | Dyskinesia, Drug-Induced - etiology | Levodopa - administration & dosage | Humans | Levodopa - adverse effects | Aged | Antiparkinson Agents - administration & dosage | Parkinson Disease - drug therapy | Antiparkinson Agents - adverse effects
Journal Article
European Journal of Neurology, ISSN 1351-5101, 02/2014, Volume 21, Issue 2, pp. 312 - 318
Journal Article
Neurology, ISSN 0028-3878, 03/2019, Volume 92, Issue 10, pp. 453 - 454
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for advanced Parkinson disease (PD) with severe motor... 
CLINICAL NEUROLOGY | LEVODOPA
Journal Article
Movement Disorders, ISSN 0885-3185, 05/2015, Volume 30, Issue 6, pp. 788 - 795
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 829 - 836
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned non-human primate is widely used to model Parkinson's disease (PD) and to evaluate the... 
l-DOPA | Parkinson's disease | Pharmacokinetics | MPTP-lesioned macaque | Dyskinesia | ANTAGONIST | LEVODOPA-INDUCED DYSKINESIAS | PHARMACODYNAMICS | CEREBROSPINAL-FLUID | NEUROSCIENCES | CARBIDOPA | MICRODIALYSIS | ANTIPARKINSONIAN ACTION | PLASMA | FLUCTUATIONS | L-DOPA | PHARMACOLOGY & PHARMACY | MONKEYS | Parkinsonian Disorders - cerebrospinal fluid | Basal Ganglia - metabolism | Half-Life | Levodopa - pharmacokinetics | Macaca fascicularis | Antiparkinson Agents - cerebrospinal fluid | Biological Availability | Metabolic Clearance Rate | Dyskinesia, Drug-Induced - prevention & control | Chromatography, High Pressure Liquid | Parkinsonian Disorders - metabolism | Tissue Distribution | Dopamine Agents - blood | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Levodopa - administration & dosage | Parkinsonian Disorders - drug therapy | Dopamine Agents - pharmacokinetics | Behavior, Animal - drug effects | Female | Levodopa - cerebrospinal fluid | Dyskinesia, Drug-Induced - etiology | Severity of Illness Index | Benserazide - administration & dosage | Parkinsonian Disorders - physiopathology | Levodopa - blood | Caudate Nucleus - metabolism | Dopamine Agents - metabolism | Antiparkinson Agents - pharmacokinetics | Animals | Antiparkinson Agents - blood | Dopamine Agents - cerebrospinal fluid | Antiparkinson Agents - metabolism | Levodopa - metabolism | Drug Combinations | Primates | Phenols | Monkeys | Analysis | Index Medicus | Drugs | Brain | Animal models | Basal ganglia | Neurodegenerative diseases | Central nervous system diseases | Mass spectroscopy | Bioavailability | Cerebrospinal fluid | Caudate nucleus | Levodopa | MPTP | Movement disorders
Journal Article